Is the increased expression of ubiquitin in CADASIL syndrome a manifestation of aberrant endocytosis in the vascular smooth muscle cells?

Journal of Clinical Neuroscience

Volumn 15, Issue 5, 2008, Pages 535-540

  Dziewulska, D ^a,b   Rafalowska, J ^b  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

^b MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

Author keywords

Angiopathy; CADASIL; Endocytosis; Granular osmiophilic material; Notch 3; Ubiquitin; Vascular dementia

Indexed keywords

NOTCH3 RECEPTOR; OSMIUM; UBIQUITIN;

ADULT; AGED; ARTICLE; BLOOD VESSEL; BRAIN BIOPSY; CADASIL; CELL MEMBRANE; CLINICAL ARTICLE; CLINICAL FEATURE; ENDOCYTOSIS; ENDOSOME; FEMALE; GENE MUTATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MACROPHAGE; MALE; NOTCH 3 GENE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; SKIN BIOPSY; SMOOTH MUSCLE FIBER; ULTRASTRUCTURE; VASCULAR SMOOTH MUSCLE;

ACTINS; ADULT; AGED; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; BRAIN; CADASIL; ENDOCYTOSIS; FEMALE; GLIAL FIBRILLARY ACIDIC PROTEIN; HUMANS; MALE; MIDDLE AGED; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; RECEPTORS, CELL SURFACE; RECEPTORS, NOTCH; UBIQUITIN;

EID: 41549116229     PISSN: 09675868     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jocn.2007.06.022     Document Type: Article

References (24)

1. Joutel A., Corpechot C., Ducros A., et al. Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia. Nature 383 (1996) 707-710
2. Joutel A., Andreux F., Gaulis S., et al. The ectodomain of the Notch3 receptor accumulates within the cerebrovasculature of CADASIL patients. J Clin Invest 105 (2000) 597-605
3. Bianchi S., Dotti M.T., and Federico A. Physiology and pathology of notch signalling system. J Cell Physiol 207 (2006) 300-308
4. Goldberg A.L. Protein degradation and protection against misfolded or damaged proteins. Science 426 (2003) 895-899
5. Hicke L. Protein regulation by monoubiquitin. Nat Rev Mol Cell Biol 2 (2001) 195-201
6. Dhananjayan S.C., Ismail A., and Nawaz Z. Ubiquitin and control of transcription. Essays Biochem 41 (2005) 69-80
7. Ciechanover A. The ubiquitin proteolytic system: From a vague idea, through basic mechanisms, and onto human diseases and drug targeting. Neurology 66 (2006) S7-S19
8. Boenish T. Immunochemical Staining Methods (1989), Dako Corp., Carpinteria, CA
9. O'Sullivan M., Jarosz J.M., Martin R.J., et al. MRI hyperintensities of the temporal lobe and external capsule in patients with CADASIL. Neurology 56 (2001) 628-634
10. Karlström H., Beatus P., Dannaeus K., et al. CADASIL-mutated Notch 3 receptor exhibits impaired intracellular trafficking and maturation but normal ligand-induced signaling. Proc Natl Acad Sci USA 99 (2002) 17119-17124
11. Joutel A., Monet M., Domenga V., et al. Pathogenic mutations associated with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy differently affect Jagged1 binding and Notch3 activity via the RBP/JK signaling pathway. Am J Hum Genet 74 (2004) 338-347
12. Peters N., Opherk C., Zacherle S., et al. CADASIL-associated Notch3 mutations have differential effects on ligand binding and ligand-induced Notch3 receptor signaling through RBP-Jk. Exp Cell Res 299 (2004) 454-464
13. Glickman MH, Ciechanover A. The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction. Physiol Rev 2002;82:373-42.
14. Hicke L. Gettin' down with ubiquitin: turning off cell surface receptors, transporters and channels. Trends Cell Biol 9 (1999) 107-112
15. Sapir A., Assa-Kunik E., Tsruya R., et al. Unidirectional Notch signaling depends on continuous cleavage of Delta. Development 132 (2005) 123-132
16. La Borgne R., Bardin A., and Schweisguth F. The roles of receptor and ligand endocytosis in regulating Notch signaling. Development 132 (2005) 1751-1762
17. Kalimo H., Viitanen M., Amberlat K., et al. CADASIL: hereditary disease of arteries causing brain infarcts and dementia. Neuropathol Appl Neurobiol 25 (1999) 257-265
18. Ishiko A., Shimizu A., Nagata E., et al. Notch3 ectodomain is a major component of granular osmiophilic material (GOM) in CADASIL. Acta Neuropathol (Berl) 112 (2006) 333-339
19. Okajima T., and Irvine K.D. Regulation of notch signaling by o-linked fucose. Cell 111 (2002) 893-904
20. Seto E.S., Bellen H.J., and Lloyd T.E. When cell biology meets development: endocytic regulation of signaling pathways. Genes Develop 16 (2002) 1314-1336
21. Lake B. Lysosomal and peroxisomal disorders. In: Graham D.I., and Lantos P.L. (Eds). Greenfield's Neuropathology Vol. 1 (1997), Arnold, London 658-754
22. Toth P., and Lazar G. Brain phagocytes may empty tissue debris into capillaries. J Neurocytol 30 (2001) 717-726
23. Joutel A., Favrole P., Labauge P., et al. Skin biopsy immunostaining with a Notch3 monoclonal antibody for CADASIL diagnosis. Lancet 358 (2001) 2049-2051
24. Lesnik Oberstein S.A., van Duinen S.G., van den Boom R., et al. Evaluation of diagnostic NOTCH3 immunostaining in CADASIL. Acta Neuropathol (Berl) 106 (2003) 107-111